Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 6/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.63 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | NT5E | P21589 | 2/20 | 0.59 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.59 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.58 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | SRC | P12931 | 1/20 | 0.56 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.56 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13970706 | 0.88 | ENPP1 (0.61) | ENPP1POLBP2RX3P2RX1TSHR | |
| SCHEMBL20325241 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL21417133 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL809284 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL7615369 | 0.86 | P2RY1 (0.64) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL23982296 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL20419314 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL20225034 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL284986 | 0.86 | P2RY1 (0.70) | P2RX3P2RX1P2RY11P2RY1P2RY2 | |
| SCHEMBL3163036 | 0.85 | P2RX1 (0.70) | P2RX3P2RX1P2RY1P2RY2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190282703-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE (ENPP) CONJUGATES AND USES THEREOF | ABBVIE INC. | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190282703-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE (ENPP) CONJUGATES AND USES THEREOF | ENPP1, ENPP3, ENPEP | ENPP1 1/4885POLB 1369/4885P2RX3 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.